News

IDDO at CUGH: connecting with the global health community

Dr James Watson becomes IDDO’s new Associate Director

World Economic Forum blog on IDDO

IDDO’s latest newsletter is out

IDDO’s Director recognised as an ASTMH Distinguished International Fellow for 2022

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

IDDO’s latest newsletter is out

IDDO at the Geneva Health Forum 4 May 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

Applications open for RSTMH 2022 grant programme

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide

IDDO to make its COVID-19 studies discoverable on the Vivli platform